Pathogenesis and management of cancer-related insomnia

Journal of Supportive Oncology

Volumn 3, Issue 5, 2005, Pages 349-359

  Graci, Gina ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC ANTIMETABOLITE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CAFFEINE; CORTICOSTEROID DERIVATIVE; CORTICOTROPIN DERIVATIVE; CYTOTOXIC AGENT; DECONGESTIVE AGENT; GLUTETHIMIDE; HYPNOTIC AGENT; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NEUROLEPTIC AGENT; OPIATE DERIVATIVE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; XANTHINE DERIVATIVE;

BEHAVIOR THERAPY; CANCER PATIENT; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; EARLY MENOPAUSE; ENDEMIC DISEASE; FATIGUE; HANGOVER; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HOSPITALIZATION; HOT FLUSH; HUMAN; INCIDENCE; INSOMNIA; MEDICAL ASSESSMENT; MOTOR DYSFUNCTION; MYOCLONUS; NAUSEA; NIGHTMARE; NURSE; ONCOLOGY; PATHOGENESIS; PHYSICIAN; PSYCHOLOGICAL ASPECT; QUALITY CONTROL; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; SLEEP DISORDER; SLEEP PATTERN; SOMNOLENCE; VOMITING;

BEHAVIOR THERAPY; HUMANS; NEOPLASMS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 26844542477     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Passik SD, Whitcomb LA, Kirsh KL, Theobald DE. An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients. J Pain Symptom Manage 2003;25:284-287.
2. Mills M, Graci G. Sleep disturbances. In: Frogge M, ed. Cancer Symptom Management. Sudbury, Mass: Jones & Bartlett Publishers; 2004:111-134.
3. Everitt DE, Avorn J, Baker MW. Clinical decision-making in the evaluation and treatment of insomnia. [erratum appears in Am J Med 1990;89:838]. Am J Med 1990;89:357-362.
4. Benca RM, Quintas J. Sleep and host defenses: a review. Sleep 1997;20:1027-1037.
5. Savard J, Morin CM. Insomnia in the context of cancer:a review of a neglected problem. J Clin Oncol 2001;19:895-908.
6. Savard J, Simard S, Blanchet J, Ivers H, Morin CM. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep 2001;24:583-590.
7. Morin CM. The nature of insomnia and the need to refine our diagnostic criteria. Psychosom Med 2000;62:483-485.
8. Ehrenberg B. Importance of sleep restoration in co-morbid disease: effect of anticonvulsants. Neurology 2000;54(5 suppl 1):S33-S37.
9. Lamberg L. Sleep disorders, often unrecognized, complicate many physical illnesses. JAMA 2000;284:2173-2175.
10. Savard J, Miller SM, Mills M, et al. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer. Psychosom Med 1999;61:496-507.
11. Benca RM. Consequences of insomnia and its therapies. J Clin Psychiatry 2001;62:(suppl 10):33-38.
12. Leger D, Guilleminault C, Dreyfus JP, Delahaye C, Paillard M.. Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res 2000;9:35-42.
13. Ohayon MM, Caulet M, Priest RG, Guilleminault C. DSM-IV and ICSD-90 insomnia symptoms and sleep dissatisfaction. Br J Psychiatry 1997;171:382-388.
14. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999;22(suppl 2):S354-S358.
15. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manage 2002;24:471-480.
16. Sarna L, Brecht ML. Dimensions of symptom distress in women with advanced lung cancer: a factor analysis. Heart Lung 1997;26:23-30.
17. Thomas C. Insomnia among individuals with cancer. Presented at the 11th Annual Congress of the Oncology Nursing Society; 1987; Denver, Co; 13:63.
18. Lindley C, Vasa S, Sawyer WT, Winer EF. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998;16:1380-1387.
19. Couzi RJ, Helzlsouer KJ, Fetting JH. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737-2744.
20. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ 2000;162:216-220.
21. American Sleep Disorders Association-Diagnostic Classification Steering Committee. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, NY: American Academy of Sleep Medicine; 1997.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994:886.
23. Edinger JD, Bonnett MH, Bootzin RR, et al. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 2004;27:1567-1596.
24. Maczaj M. Pharmacological treatment of insomnia. Drugs 1993;45:44-55.
25. Aldrich M. Cardinal manifestations of sleep disorders. In: Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement WC, eds. Philadelphia, Pa: WB Saunders; 2000:526-528.
26. Bastien CH, Vallieres A, Morin CM. Precipitating factors of insomnia. Behav Sleep Med 2004;2:50-62.
27. Lee KA. An overview of sleep and common sleep problems. ANNA J 1997;24:614-623, 677.
28. Massie M, Popkin M. Depressive disorders. In: Holland J,ed. Psycho-Oncology. New York, NY: Oxford University Press; 1998:518-540.
29. van't Spijker A, Trijsburg RW, Duivenvoorden HJ. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 1997;59:280-293.
30. Noyes R, Holt C, Massie M. Anxiety disorders. In: Holland J, ed. Psycho-Oncology. New York, NY: Oxford University Press; 1998:548-563.
31. Jacobs-Rebhun S, Schnurr PP, Friedman MJ, et al. Posttraumatic stress disorder and sleep difficulty. Am J Psychiatry 2000;157:1525-1526.
32. Silberfarb PM, Hauri PJ, Oxman TE, Schnurr P. Assessment of sleep in patients with lung cancer and breast cancer. J Clin Oncol 1993;11:997-1004.
33. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med 2002;54:1309-1321.
34. Sandek K, Andersson T, Bratel T, Hellstrom G, Lagerstrand L. Sleep quality, carbon dioxide responsiveness and hypoxaemic patterns in nocturnal hypoxaemia due to chronic obstructive pulmonary disease (COPD) without daytime hypoxaemia. Respir Med 1999;93:79-87.
35. Kimura K, Adlakha A, Staats BA, Shepard JW Jr. Successful treatment of obstructive sleep apnea with use of nasal continuous positive airway pressure in three patientswith mucosal hemangiomas of the oral cavity. Mayo Clin Proc 1999;74:155-158.
36. Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M.Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 1993;8:196-200.
37. Simpson T, Lee ER, Cameron C. Patients'perceptions of environmental factors that disturb sleep after cardiac surgery. Am J Crit Care 1996;5:173-181.
38. Southwell MT, Wistow G. Sleep in hospitals at night: are patients' needs being met? J Adv Nurs 1995;21:1101-1109.
39. Closs SJ. Patients' night-time pain, analgesic provision and sleep after surgery. Int J Nurs Stud 1992;29:381-392.
40. Osoba D, Zee B, Warr D, et al. Effect of postchemotherapy nausea and vomiting on health-related quality of life.The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer 1997;5:307-313.
41. National Cancer Institute. Sleep disorders. Available at: http://www.nci.nih.gov/cancertopics/pdq/supportivecare/sleepdisorders/ patient/allpages. Accessed July 22, 2005.
42. Kupfer DJ, Reynolds CF 3rd. Management of insomnia. N Engl J Med 1997;336:341-346.
43. Lazarus H, Fitzmartin RD, Goldenheim PD. A multi-investigator clinical evaluation of oral controlled-release morphine (MS Contin tablets) administered to cancer patients. Hosp J 1990;6:1-15.
44. Moore P, Dimsdale JE. Opioids, sleep, and cancer-related fatigue. Med Hypotheses 2002;58:77-82.
45. Ferris DJ. Controlling myoclonus after high-dosage morphine infusions. Am J Health Syst Pharm 1999;56:1009-1010.
46. Donnelly S, Davis MP, Walsh D, et al. Morphine in cancer pain management: a practical guide. Support Care Cancer 2002;10:13-35.
47. Stepanski EJ. The effect of sleep fragmentation on daytime function. Sleep 2002;25:268-276.
48. Walter T, Golish J. Psychotropic and neurologic medications. In: Lee-Chiong Jr TL, Sateia M, Carskadon M, eds. Sleep Medicine. Philadelphia, Pa: Hanley & Belfus Inc.; 2002:587-599.
49. Oberndorfer S, Saletu-Zyhlarz G, Saletu B. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychobiology 2000;42:69-81.
50. Stepanski E, ed. Etiology of insomnia. In: Lee-Chiong Jr TL, Sateia M, Carskadon M, eds. Sleep Medicine. Philadelphia, Pa: Hanley & Belfus Inc.; 2002:161-168.
51. Hirshkowitz M. Somnopharmacology. In: National Sleep Medicine Course. Leesburg, Va: American Academy of Sleep Medicine; 2001.
52. Michelini S, Cassano GB, Frare F, Perugi G. Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders. Pharmacopsychiatry 1996;29:127-134.
53. Puntillo K, Casella V, Reid M. Opioid and benzodiazepine tolerance and dependence: application of theory to critical care practice. Heart Lung 1997;26:317-324.
54. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225-233.
55. Roehrs T, Roth T. Hypnotics: efficacy and adverse effects. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia, Pa: WB Saunders; 2001:414-418.
56. Holbrook A, Crowther R, Lotter A, Endeshaw Y. The role of benzodiazepines in the treatment of insomnia: meta-analysis of benzodiazepine use in the treatment of insomnia. J Am Geriatr Soc 2001;49:824-826.
57. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998;16:1689-1696.
58. Owen DC, Parker KP, McGuire DB. Comparison of subjective sleep quality in patients with cancer and healthy subjects. Oncol Nurs Forum 1999;26:1649-1651.
59. Berger AM, Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum 2000;27:1443-1448.
60. Berger AM. Patterns of fatigue and factors influencing fatigue during adjuvant breast cancer chemotherapy [dissertation]. Omaha, Neb: University of Nebraska Medical Center; 1997.
61. Berger AM, Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum 1999;26:1663-1671.
62. Irwin M, Smith TL, Gillin JC. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med 1992;54:10-21.
63. Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 1999;17:320-332.
64. Knobf MT. Natural menopause and ovarian toxicity associated with breast cancer therapy. Oncol Nurs Forum 1998;25:1519-1530.
65. Engstrom CA, Strohl RA, Rose L, Lewandowski L, Stefanek ME. Sleep alterations in cancer patients. Cancer Nurs 1999;22:143-148.
66. Turner R, Elson E. Sleep disorders: steroids cause sleep disturbance. BMJ 1993;306:1477-1478.
67. Meyer TJ, Eveloff SE, Bauer MS, et al. Adverse environmental conditions in the respiratory and medical ICU settings. Chest 1994;105:1211-1216.
68. Nelson JE, Meier DE, Oei EJ, et al. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001;29:277-282.
69. Hauri PJ. Insomnia. In: National Sleep Medicine Course. Leesburg, Va: American Academy of Sleep Medicine; 2001.
70. Hauri PJ. The cognitive-behavioral treatment of insomnia. In: Stunkard AJ, Baum A, eds. Eating, Sleeping, and Sex: Perspectives in Behavioral Medicine. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc: 1989:181-194.
71. Bastien C, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307.
72. Stepanski E, Rybarczyk B, Lopez M, Steven S. Assessment and treatment of sleep disorders in older adults: a review for rehabilitation psychologists. Rehabil Psychol 2003;48:23-36.
73. Littner M, Hirshkowitz M, Kramer M, et al. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep 2003;26:754-760.
74. Lavie P, Pillar G, Malthotra A, eds. Sleep Disorders: Diagnosis, Management and Treatment: A Handbook for Clinicians. 1st ed. Florence, Ky:Taylor & Francis; 2002.
75. Dooley M, Plosker GL. Zaleplon: a review of its use in the treatment of insomnia. Drugs 2000;60:413-445.
76. Stepanski E, Zorick F, Roth T. Pharmacotherapy of insomnia. In: Hauri PJ, ed. Case Studies in Insomnia (Critical Issues in Psychiatry). New York, NY. Plenum Publishing; 1991:115-129.
77. Manber R, Kuo T. Cognitive-behavioral therapies for insomnia. In: Lee-Chiong Jr TL, Sateia M, Carskadon M, eds. Sleep Medicine. Philadelphia, Pa: Hanley & Belfus Inc.; 2002:177-185.